In contrast to this study, rheumatoid arthritis patients had significantly lower proportions of peripheral blood CD19+FoxP3+ B cells as compared to healthy controls, particularly in patients with interstitial lung disease. This evidence concerns the gene CD19 and rheumatoid arthritis.